PharmaLogic Executive and Leadership Team

Etienne Montagut, the President & Chief Executive Officer at PharmaLogic, directs the overarching corporate strategy for the global contract development and manufacturing organization. By aligning the development of diagnostic and therapeutic radiopharmaceuticals with market demand, the President & Chief Executive Officer ensures long-term growth across North American and European markets. Etienne Montagut maintains direct oversight of the executive leadership team, fostering collaboration between manufacturing and clinical research divisions to optimize product distribution. This leadership role involves constant engagement with the Board to refine the company mission and expand the reach of radiopharmaceutical products to healthcare providers. Through rigorous assessment of industry trends, the President & Chief Executive Officer drives innovation in the CDMO space. Ultimately, Montagut secures the competitive position of the organization by prioritizing high-quality manufacturing standards and strategic partnerships that enhance patient outcomes globally.

Mark Dmytruk, the Chief Financial Officer at PharmaLogic, manages the fiscal health and capital allocation strategies for the global radiopharmaceutical manufacturing network. Overseeing financial planning, reporting, and risk management, the Chief Financial Officer ensures the organization maintains the liquidity required for expanding manufacturing facilities across North America and Europe. Mark Dmytruk collaborates with the executive team to evaluate investment opportunities in new diagnostic and therapeutic technologies. This leadership role involves maintaining transparency with stakeholders while optimizing the cost structure of the CDMO operations. By implementing robust financial controls, the Chief Financial Officer supports the sustainable growth of the company. Dmytruk monitors market volatility to protect the financial interests of the organization, ensuring that capital resources align with the core mission of delivering essential medical products to pharmaceutical partners and healthcare providers worldwide.

Glen Palmer, the Chief Operating Officer at PharmaLogic, executes the daily operational strategy across the entire network of radiopharmacies and manufacturing facilities. Managing the complex supply chain for diagnostic and therapeutic radiopharmaceuticals, the Chief Operating Officer ensures seamless production and distribution to healthcare providers throughout North America and Europe. Glen Palmer optimizes manufacturing workflows to increase efficiency and maintain strict regulatory compliance within the CDMO framework. This leadership role involves coordinating with site managers to scale production capacity in response to rising clinical demand. By streamlining operational processes, the Chief Operating Officer drives the consistent delivery of high-quality products to pharmaceutical partners. Palmer monitors performance metrics to identify bottlenecks, implementing solutions that enhance the overall output of the organization. Ultimately, the Chief Operating Officer maintains the operational excellence necessary to support the company's global market presence.

Timothy Quinton, the President at PharmaLogic, drives the regional business development and commercial expansion of the radiopharmaceutical product portfolio. Focusing on the growth of the CDMO services, the President identifies new market opportunities for diagnostic and therapeutic products across North America and Europe. Timothy Quinton manages relationships with key pharmaceutical partners, ensuring that the company meets the specific needs of healthcare providers through tailored manufacturing solutions. This leadership role involves overseeing the commercial strategy to increase market share and enhance the visibility of the organization's capabilities. By aligning regional sales efforts with corporate objectives, the President supports the overall revenue goals of the company. Quinton monitors competitive dynamics to refine the commercial approach, ensuring that the organization remains a preferred partner in the industry. Ultimately, the President secures the commercial viability of the company through proactive market engagement and strategic client management.

Hallie Pierson, the Chief People Officer at PharmaLogic, architects the human capital strategy to support the global workforce across North American and European operations. Directing talent acquisition, organizational development, and employee engagement, the Chief People Officer ensures the company attracts the specialized expertise required for radiopharmaceutical manufacturing. Hallie Pierson fosters a culture of innovation and safety, aligning personnel goals with the broader mission of delivering therapeutic solutions to healthcare providers. This leadership role involves designing compensation structures and training programs that retain top-tier talent within the competitive CDMO industry. By implementing inclusive workplace policies, the Chief People Officer drives organizational performance and employee satisfaction. Pierson collaborates with other executives to ensure that the workforce remains agile and prepared for future expansion. Ultimately, the Chief People Officer secures the human infrastructure necessary for the long-term success of the organization.

Pamela Wong, the Chief Legal Officer at PharmaLogic, manages the legal framework and regulatory compliance for the global radiopharmaceutical manufacturing network. Overseeing intellectual property, contract negotiations, and international trade regulations, the Chief Legal Officer ensures the organization operates within the complex legal environments of North America and Europe. Pamela Wong provides critical guidance on the development and distribution of diagnostic and therapeutic products, mitigating risks associated with pharmaceutical manufacturing. This leadership role involves advising the Board on governance matters and ensuring adherence to industry-specific safety standards. By navigating the legal landscape, the Chief Legal Officer protects the company's assets and supports strategic partnerships with healthcare providers. Wong coordinates with external counsel to resolve disputes and maintain the integrity of the organization's operations. Ultimately, the Chief Legal Officer secures the legal foundation required for the company to innovate and grow.